Two members of our Client Solutions Group detail their research on how executives could view equity compensation in the latest issue of Investment & Monitor magazine.
While it’s unknown whether legislation will get passed this year, taking advantage of current rates now could work to your advantage.
Given that tax reform is likely to be a top priority for 2017, here are some important considerations to discuss now with your tax advisor.
A decision requiring Parliamentary approval of Brexit sparks new uncertainty about if and when the U.K. will leave the EU.
London-based Portfolio Manager discusses the potential implications of Brexit and where he is finding compelling opportunities in the market.
It took nearly a decade, but the euro zone finally surpassed its previous peak levels of economic output in the first quarter.
Comparatively high interest rates in the U.S. have pushed the greenback up against most currencies. The shift is having widely varying effects around the world.
Avoid the urge to time the market because history shows that staying put and systematically adding to your holdings is a better strategy.
In this interview, Greg Fuss, global equity portfolio manager for Capital Group Private Client Services, discusses recent volatility in the stock market and where he's finding compelling investment opportunities.
Much has gone right for municipal bonds, but the financial difficulties of Detroit and Puerto Rico are a reminder of the potential downside.
A leading industry publication features strategies for optimizing charitable giving opportunities from Michelle J. Black, head of the Capital Group Private Client Services Wealth Advisory Group.
Chris Bailey has spent a year of his life conducting various experiments to uncover the secrets to peak productivity. In this interview, Chris discusses some of his top recommendations.
In our annual Investment Roundtable, our stock and bond investment teams offer their perspectives on current market conditions and discuss how they are investing client assets.
Selling a company is complex and entails a variety of decisions. Here are eight steps that can benefit those contemplating a business sale.
Equity Analyst Patrice Collette was drawn to cars long before he was old enough to drive one himself. He shares a few thoughts for those who may be interested in cars as either a hobby or a potential investment.
Concerns about China's economy have dominated the news, but there's a lot going right as well. Among other things: the use of advanced technologies and a move toward efficient automation.
Most of the past decade, fixed-income investors have benefited from low inflation. While inflation is unlikely to skyrocket, consumer prices could begin to move higher as U.S. and global economies improve.
Far from being a relic of a bygone era, the freight rail industry is undergoing a powerful renaissance. Improved performance and dependability have made the sector a growing force in the U.S.
After decades of being held back, a powerful shift is under way. Women in India are steadily gaining access to education and to jobs in coveted fields such as finance and technology.
Investing in art, wine and other hobbies is referred to as passion investing. It has become increasingly popular over the years. Here's how to view this as part of an overall portfolio.
In this issue of Quarterly Insights we outline how women in India are changing the investing landscape, discuss the emergence of fast-casual dining industry and show how sound habits lead to greater happiness.
In this interview, New York Times columnist Ron Lieber discusses the challenges of talking about money with your kids and raising them to be more grounded, generous and financially savvy.
The traditional TV model is yielding to a new world of on-demand entertainment over the Internet and will likely have major consequences for the entertainment industry.
Though the government’s efforts are far from complete, signs of progress have begun to emerge in Japan's economy, including rising corporate profits and improved job growth.
For decades, medical researchers have struggled to find better ways to fight cancer. Now biopharmaceutical companies are making dramatic advances in an emerging area known as immuno-oncology that could be a game changer in fighting the disease.